Beyond Meat sales recovery remains elusive as another drop forecast

Beyond Meat sales recovery remains elusive as another drop forecast
Beyond Meat sales recovery remains elusive as another drop forecast

Beyond Meat is forecasting another drop in sales in the second quarter after posting a 15% drop in the first three months of the year.

Shares of the plant protein company closed higher on the Nasdaq yesterday (May 6) despite reporting a 15.3% decline in first-quarter sales to $58.2 million and a total loss in volumes of 19.5%.

Sales in the current second quarter are forecast between $60 million and $65 million, down from $75 million in the same period a year ago.

However, there were some positives in Beyond Meat’s first-quarter numbers. The adjusted EBITDA loss in the period to March 28 narrowed to $27.8 million from a loss of $50.5 million a year earlier. Net losses narrowed to $28.5 million from $61.1 million.

Beyond Meat shares ended the US trading day up 13.2% at $1.04, bringing the 2026 gain to just over 18%.

However, more than 59% has fallen from the value of Beyond Meat’s share price in the last 12 months amid a combination of falling sales, net losses, cash burn, inventory adjustments, impairment charges and delisting warnings.

“The company continues to experience a high level of uncertainty and volatility within its operating environment, which has, and may continue to have, unforeseen impacts on the company’s actual results,” Beyond Meat said yesterday in setting out its sales outlook for the second quarter.

Despite the January announcement of the company’s entry into “plant-based protein” beverages, founder, president and CEO Ethan Brown said the focus remains on the core alternative meat business.

“This quarter marked a decisive expansion of our business openness to include the rapidly growing functional foods and beverages category,” Brown said in yesterday’s earnings commentary.

“Even as we apply our brand, expertise and technology to adjacent markets, we remain highly focused on the performance of our core business, which we believe will deliver substantial long-term value. To this end, we are pleased to report a significant improvement in operating expenses and our lowest quarterly cash burn in more than two years.”

First-quarter operating expenses fell to $43.1 million from $57.4 million in the corresponding period. Net cash used in operations fell to $5 million from $26.1 million.

Beyond Meat’s narrowing operating profit loss to $41.1 million from a loss of $64.4 million a year earlier was another positive, but first-quarter sales declined across nearly all business segments and geographies.

The exception was international retail, where sales rose 8.1% to $13.71 billion with a slight 0.3% increase in volumes. Otherwise, foodservice sales and volumes in that channel and region decreased by 25.9% and 32.6%, respectively.

Out-of-home sales in the United States fell 29.7% with a volume loss of 31.8%. US retail trade fell 15.3% with a 14.7% decline in volumes.

“The decrease in product volume sold was primarily due to lower sales of hamburger and chicken products to quick-service restaurant (QSR) customers in the international foodservice channel, and weak demand for the category and reduced distribution points in the U.S. retail and foodservice channels,” Beyond Meat explained.

John Baumgartner, CEO of Mizuho Securities, wrote yesterday that “pressures remain” and that the first-quarter weakness “was largely as expected.”

He said in a research note that “the scale of negative surprises may be softening given already low Street expectations,” but added: “However, that does not mitigate the magnitude of the year-over-year sales declines that remain very concerning in three of the four business units, and elevate the importance of Beyond’s success in building its new line of fortified protein-dipped beverages.”

“Beyond Meat sales recovery remains elusive as another drop predicted” was created and originally published by Just Food, a brand owned by GlobalData.


The information contained on this site has been included in good faith for general information purposes only. It is not intended to be advice on which you should rely, and we make no representation or warranty, whether express or implied, as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action based on the content on our site.

Source link